Home
>
National Drug Code (NDC)
>
GANCICLOVIR
GANCICLOVIR - 63304-637-28 - (GANCICLOVIR)
Drug Information of GANCICLOVIR
| Product NDC: | 63304-637 |
| Proprietary Name: | GANCICLOVIR |
| Non Proprietary Name: | GANCICLOVIR |
| Active Ingredient(s): | 500 mg/1 & nbsp; GANCICLOVIR |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GANCICLOVIR
| Product NDC: | 63304-637 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076457 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030827 |
Package Information of GANCICLOVIR
| Package NDC: | 63304-637-28 |
| Package Description: | 180 CAPSULE in 1 BOTTLE (63304-637-28) |
NDC Information of GANCICLOVIR
| NDC Code | 63304-637-28 |
| Proprietary Name | GANCICLOVIR |
| Package Description | 180 CAPSULE in 1 BOTTLE (63304-637-28) |
| Product NDC | 63304-637 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GANCICLOVIR |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030827 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | GANCICLOVIR |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
